Request Podcast

Transcript of CBD Oil vs Copaiba Oil – Dr. Hill and Dr. O Discuss How CBD and Copaiba Work

Our favorite podcasts
Published about 5 years ago 1,022 views
Transcription of CBD Oil vs Copaiba Oil – Dr. Hill and Dr. O Discuss How CBD and Copaiba Work from Our favorite podcasts Podcast
00:00:00

Everyone, Dr.

00:00:01

David Hill here with my good friend, Dr.

00:00:03

Russell Laska Thorpe.

00:00:05

Russell, welcome.Thank you.

00:00:06

Nice to have you here.

00:00:07

I'd like to take a momentjust to introduce herself.

00:00:10

Sure you are.My name is Dr.

00:00:11

Oz Thorpe.You can call me Dr.

00:00:13

.

00:00:13

I'm a pediatric infectious disease doctor,and I'm really glad to be at Doctora.

00:00:17

Well, we're happy to have you here.

00:00:19

And today we're going to talka little bit about Capalaba and CBD.

00:00:23

I would like to put it into a contextof four very specific things.

00:00:27

And this is going to surprise you.

00:00:28

But price purity.

00:00:31

Yeah, potency.

00:00:33

And then I'd also like to talk about somenew discovery we're making for pathway.

00:00:37

Yeah.

00:00:37

And I want to relate those allto CBD and this comparison to fiber.

00:00:42

And one of the things that we know about

00:00:43

CBD is that everybody has hadseemingly great experience.

00:00:48

We know that there's a good amountof information that's available and we

00:00:51

don't want to bediscounting of any of that.

00:00:53

So let's just talk somevery specific things.

00:00:56

When you think of those first threethings, price, potency and purity,

00:01:00

what comes to mind to youin the marketplace today?

00:01:04

CBD is flooded all over the place.

00:01:07

It's in every product imaginable,

00:01:09

from mascara to doggie treatsand everything in between.

00:01:12

The trouble is that when people are taking

00:01:14

it to help them with problems that theyhave with their health,

00:01:19

the doses that are required are so highthat the price point is really painful.

00:01:23

Well, it becomes painful and becomesunobtainable for most people.

00:01:27

And purity is a different animal for me.

00:01:29

I'm going to drill themon this just a little bit.

00:01:31

It's still Tear's calling it.

00:01:32

It's it's what we do.It's what we know.

00:01:35

And I know the intensitythat goes with that.

00:01:36

And in an industry that, as you indicated,has this plethora of products,

00:01:41

we see a lot of inconsistencies in termsof the amount that's available of the CBD,

00:01:47

where some of the differencethat you see that.

00:01:48

Well, the trouble with CBD is

00:01:52

that the hemp industry where CBD comesfrom is not very regulated

00:01:57

and the products that are madeare not checked for purity.

00:02:01

And the amount of CBD within those

00:02:04

products can be highly variablebecause of the dissonance that exists

00:02:09

between the federal and statestatutes around CBD.

00:02:12

Right.

00:02:13

It's not a good time for us asa company to enter that arena.

00:02:17

Let's look at the Indo cannabinoid systemCB1 CB2 receptors.

00:02:23

Join me to explain it really quickly.

00:02:24

A very quick for everybody to understand

00:02:26

so that the endocannabinoid system in ourbody controls a whole host of things.

00:02:30

Eat, sleep, forget, relax,

00:02:32

and the receptor tone matters and youchange that receptor tone by these

00:02:37

chemicals that our bodymakes for ourselves.

00:02:39

We call them endocannabinoids.

00:02:41

In the plant world.

00:02:42

There are lots of chemicals that plants

00:02:44

make that interact with ourown body's receptors.

00:02:47

They call they're calledphyto cannabinoids.

00:02:49

And CBD is one of thosebeta carotene as another.

00:02:53

Right.And that potency issue,

00:02:55

how much power you get to that system,either up regulating or down regulating

00:03:00

that system depends on howyou bind to those receptors.

00:03:04

And beta karrar offline isa direct binder to the system.

00:03:07

Correct.And CBD is an indirect binder.

00:03:10

So this offers some explanation whywe're not saying that CBD has no value.

00:03:16

It's just a different circumstance.

00:03:18

Correct, in the amount that we havepresent within those two products.

00:03:21

By comparison,when we look at Captivities Santoya,

00:03:24

when we look at CBD,they're very different,

00:03:26

they're very different,and we really don't compare them.

00:03:29

And this is one of the thingsthat I've become most excited about

00:03:32

with Kaposvar is that the beta carotene,this phyto cannabinoid that you talked

00:03:37

about, that in and of itselfresides in substantial amounts.

00:03:42

There's really little question about arewe getting some efficacious dosages

00:03:47

associated with that? The potency that youcan obtain by getting a purified product

00:03:51

from Capalaba with bettercare of is quite high.

00:03:54

I really get excited about what we'recurrently discovering with Path Pathway.

00:03:59

And so let's talk about that,because you've already indicated that one

00:04:03

of the differences that we see as weactivate this system and we're talking

00:04:08

about CB2 receptors,we have indirect consequence and direct

00:04:12

consequence in the downstream effect thatboth of those create that we're after.

00:04:17

So binding at the receptorlevel is really important.

00:04:20

But what matters in the cell is how youget to your end result, which is changing

00:04:27

DNA, proteins, enzymes,the cellular functions

00:04:32

and direct binding at these receptors haseffects that will drive cellular

00:04:39

mechanisms to change certainoutcomes within the body.

00:04:42

One of the other things that I have liked

00:04:44

about Capalaba as an essential oilproduct is the diversity that we see.

00:04:49

It's not just Feydeaucannabinoid that's there.

00:04:52

It's not just the Medicare Offaly.

00:04:54

We have lots of other chemistryand that provides some diversity for us.

00:04:58

And so unlike.

00:04:59

The CBD, when we look at Capalaba as

00:05:02

an essential oil,we have potential for other benefits

00:05:05

that really can even resideoutside of the endocannabinoids.

00:05:09

When we when we talk about Capalaba, we'renot just talking about Baedeker offline.

00:05:13

I agree.

00:05:14

There are many molecules withinthe essential oil,

00:05:17

many of which have plant chemistry behindthem, where we know that there are going

00:05:22

to be other effects than just simply theendocannabinoid system, Baedeker offline.

00:05:27

However, being a major component,and that's one of the things that we love

00:05:30

about it, is that we'reconfident we have potency.

00:05:33

We know that we have purity and we know

00:05:35

that it's directed to thecannabinoid system.

00:05:40

I've seen a bottle of CBD

00:05:43

sometimes sell for hundreds of dollars.Sure.

00:05:46

And the amount that I would have

00:05:47

to consume based on the discussionthat we've had is exponentially higher

00:05:52

than what we would see with something likeCapalaba that has higher chemistry,

00:05:57

certainly not hundredsof dollars a bottle.

00:05:59

And we've also know and have lookedat the research and know

00:06:02

that by comparison we can have very smalldosage amounts and still create

00:06:07

the benefit in the effectthat we're looking for.

00:06:09

That, to me, is oneof the critical things.

00:06:11

I get greater benefit from theco-payment and higher value.

00:06:14

I get greater efficacy and Ihave much higher value.

00:06:17

I come back to as well those four P's.

00:06:19

I think it's the foundationof what DR does.

00:06:24

Purity and price are extremely important

00:06:26

when you're talking abouta product like this.

00:06:28

And I think that Capalaba will

00:06:30

define itself in the marketplacequite nicely over time.

AI Transcription provided by HappyScribe